Example: Heart Attack

Clinical Trials on Non-alcoholic Fatty Liver Disease

Total 364 results

  • NCT04857606
    Recruiting
    Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease
    Conditions: Non-alcoholic Fatty Liver Disease
  • NCT04938843
    Not yet recruiting
    Effect of F. Prausnitzii on Glycemic Control
    Conditions: Pre Diabetes, Impaired Glucose Tolerance, Non-Alcoholic Fatty Liver Disease
  • NCT04216589
    Recruiting
    Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
    Conditions: HIV Infections, Non-Alcoholic Fatty Liver Disease
  • NCT03867487
    Suspended
    SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
    Conditions: Non-Alcoholic Fatty Liver Disease, NAFLD, Pediatric NAFLD
  • NCT04857437
    Recruiting
    Study in Healthy Adults Evaluating PF-07202954
    Conditions: Non-Alcoholic Fatty Liver Disease, Liver Fibrosis
  • NCT04048876
    Recruiting
    Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
    Conditions: Non-alcoholic Fatty Liver Disease, Liver Cirrhosis
  • NCT02754037
    Recruiting
    Non-Invasive Evaluation of Liver Steatosis, Inflammation and Fibrosis
    Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
  • NCT04918732
    Recruiting
    NAFLD Primary Care
    Conditions: Non-Alcoholic Fatty Liver Disease, Cardiovascular Diseases, Type2 Diabetes, Metabolic Syndrome, Overweight and Obesity
  • NCT04899102
    Recruiting
    Intermittent Fasting for NAFLD in Adults
    Conditions: Fatty Liver, Intermittent Fasting, Fatty Liver, Nonalcoholic, Non-Alcoholic Fatty Liver Disease, Liver Fat
  • NCT04907721
    Recruiting
    Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis
    Conditions: Non-Alcoholic Fatty Liver Disease, Glucagon Resistance, Type 1 Diabetes, Obesity
  • NCT04283942
    Active, not recruiting
    Effect of Intermittent Calorie Restriction on NAFLD Patients With Disorders of Glucose Metabolism
    Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD), Disorders of Glucose Metabolism, Type 2 Diabetes, Impaired Glucose Regulation
  • NCT04019561
    Completed
    A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.
    Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
  • NCT01790984
    Completed
    How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?
    Conditions: Non-alcoholic Fatty Liver Disease (NAFLD)
  • NCT04639414
    Recruiting
    Combined Active Treatment in Type 2 Diabetes With NASH
    Conditions: Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD)
  • NCT04043585
    Recruiting
    Bariatric Surgery on NASH
    Conditions: Non-Alcoholic Fatty Liver Disease, Obesity
  • NCT03938246
    Recruiting
    Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
    Conditions: Non-Alcoholic Fatty Liver Disease
  • NCT04882644
    Recruiting
    Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD)
    Conditions: Non-alcoholic Fatty Liver Disease
  • NCT04336618
    Recruiting
    Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population
    Conditions: Non-Alcoholic Fatty Liver Disease
  • NCT04820036
    Recruiting
    A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
    Conditions: Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD), Endoscopic Ultrasound, Liver Function, Obesity, Liver Fibroses
  • NCT04807868
    Recruiting
    AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
    Conditions: Non-Alcoholic Fatty Liver Disease
  • NCT04341246
    Recruiting
    Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)
    Conditions: Non-Alcoholic Fatty Liver Disease
  • NCT04422496
    Completed
    The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects
    Conditions: Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
  • NCT03915002
    Recruiting
    Integrated Approaches for Identifying Molecular Targets in Liver Disease
    Conditions: Alcoholic Liver Disease, Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Steatohepatitis
  • NCT03743272
    Recruiting
    Repeatability and Reproducibility of Multiparametric MRI
    Conditions: Liver Diseases, Primary Biliary Cirrhosis, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Cirrhosis, Hemochromatosis, Viral Hepatitis, Autoimmune Hepatitis, Primary Sclerosing Cholangitis
  • NCT02124577
    Recruiting
    Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD
    Conditions: Non-alcoholic Fatty Liver Disease
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations